N@N

Sudan Loganathan Initiated (BPMC) at Buy and Held Target at $140 on, May 14th, 2024

^{Published on 2024-10-28 11:20:41 - WOPRAI, Sudan Loganathan}
 

Sudan Loganathan of Stephens & Co., Initiated "Blueprint Medicines Corporation" (BPMC) at Buy and Held Target at $140 on, May 14th, 2024.

Sudan has made no other calls on BPMC in the last 4 months.

There are 10 other peers that have a rating on BPMC. Out of the 10 peers that are also analyzing BPMC, 3 agree with Sudan's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Andrew Berens of "Leerink Partners" Upgraded from Sell to Hold and Increased Target to $97 on, Monday, May 6th, 2024
• Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $75 on, Friday, May 3rd, 2024
• Christopher Raymond of "Piper Sandler" Maintained at Hold with Increased Target to $104 on, Friday, May 3rd, 2024

These are the ratings of the 7 analyists that currently disagree with Sudan

---

• Terence Flynn of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $168 on, Monday, May 6th, 2024
• Ami Fadia of "Needham" Maintained at Strong Buy with Increased Target to $130 on, Friday, May 3rd, 2024
• Reni Benjamin of "JMP Securities" Maintained at Buy with Increased Target to $125 on, Friday, May 3rd, 2024
• Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $135 on, Friday, May 3rd, 2024
• David Lebowitz of "Citigroup" Maintained at Strong Sell with Increased Target to $76 on, Friday, May 3rd, 2024
• David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $110 on, Friday, April 26th, 2024
• Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Friday, April 26th, 2024

Contributing Sources

---